Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive secretion of parathyroid hormone ...

MBX Biosciences Inc. MBX on Thursday reported full results from its 12-week Avail Phase 2 trial and new one-year data from an ...

Researchers from Emory University and Columbia University have uncovered a link between the gut microbiome and bone loss in ...

Applying a pretreatment of a parathyroid hormone, commonly used to increase bone mass to combat osteoporosis, can help improve cartilage health and slow the development of osteoarthritis, Cornell ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Please provide your email address to receive an email when new articles are posted on . Adults with chronic hypoparathyroidism treated with recombinant human parathyroid hormone 1-84 for 5 years ...

Please provide your email address to receive an email when new articles are posted on . The researchers conducted a prospective, population-based, longitudinal cohort study of women from the Malmö ...

Bones are not stagnant structures. According to recent studies, bones maintain a lively metabolism and closely interact via nerves with the brain. But whether endocrine hormones also play an important ...

Parathyroid cancer is very rare. Most cases of parathyroid disease, including almost all cases of overactive parathyroid, are not cancer. At Fred Hutchinson Cancer Center, our endocrine tumor ...

Parathyroid cancer is a very rare type of cancer that starts in the parathyroid gland. It can cause hyperparathyroidism, which can result in high calcium levels in the blood. The most common treatment ...